Zajac’s study, “Intrinsic IL-2 production by effector CD8 T cells affects IL-2 signaling and promotes fate decisions, stemness, and protection,” was published in Science Immunology. “In this report, ...

CD8+ T cells are essential in the fight against viruses but ... presented a novel interleukin 2 (IL-2)-based immunotherapy approach that used a modular cis-targeting platform to tackle HBV infection ...

AB359 is Asher Bio’s CD8-targeted interleukin-2 (IL-2) immunotherapy for the treatment of chronic viral infection. The data will be presented in a poster presentation at the American Association ...

AB359 is Asher Bio’s CD8-targeted interleukin-2 (IL-2) immunotherapy for the treatment of chronic viral infection. The data will be presented in a poster presentation at the American Association for ...